TY - JOUR
T1 - Increased affinity of type II corticosteroid binding in aged rat hippocampus
AU - Landfield, Philip W.
AU - Eldridge, J. Charles
PY - 1989/10
Y1 - 1989/10
N2 - Hippocampal tissue from young-mature (3-4 months old) and aged (24-26 months old) Fischer-344 rats was assessed for type I and type II corticosteroid binding in cytosol, using [3H]dexamethasone and selective inhibition of type II sites with nonradioactive RU-28362. Twenty-four hours after adrenalectomy, the Bmax and Kd of the receptor subtypes were measured by Scatchard analysis for individual animals. The binding capacity of each receptor type was significantly reduced in aged rats, as others have reported. In addition, however, the dissociation constant (Kd), was significantly reduced for type II receptor (young Kd = 2.14 nM vs aged Kd = 0.89 nM, P < 0.005), indicating greater affinity of type II sites with aging. Affinity of type I sites was unchanged. The observation of increased type II affinity could help to explain the apparent paradox of why corticosteroid-dependent degenerative changes in hippocampal cells seem to accelerate in the later stages of aging, even though brain corticosteroid receptor capacity has been reported to decline or remain unchanged with aging.
AB - Hippocampal tissue from young-mature (3-4 months old) and aged (24-26 months old) Fischer-344 rats was assessed for type I and type II corticosteroid binding in cytosol, using [3H]dexamethasone and selective inhibition of type II sites with nonradioactive RU-28362. Twenty-four hours after adrenalectomy, the Bmax and Kd of the receptor subtypes were measured by Scatchard analysis for individual animals. The binding capacity of each receptor type was significantly reduced in aged rats, as others have reported. In addition, however, the dissociation constant (Kd), was significantly reduced for type II receptor (young Kd = 2.14 nM vs aged Kd = 0.89 nM, P < 0.005), indicating greater affinity of type II sites with aging. Affinity of type I sites was unchanged. The observation of increased type II affinity could help to explain the apparent paradox of why corticosteroid-dependent degenerative changes in hippocampal cells seem to accelerate in the later stages of aging, even though brain corticosteroid receptor capacity has been reported to decline or remain unchanged with aging.
UR - http://www.scopus.com/inward/record.url?scp=0024456923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024456923&partnerID=8YFLogxK
U2 - 10.1016/0014-4886(89)90153-2
DO - 10.1016/0014-4886(89)90153-2
M3 - Article
C2 - 2792294
AN - SCOPUS:0024456923
SN - 0014-4886
VL - 106
SP - 110
EP - 113
JO - Experimental Neurology
JF - Experimental Neurology
IS - 1
ER -